$2.54
-0.06 (-2.31%)
EXACT Sciences Corp (EXAS)
CAPS Rating:
An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.
No one has written a Pitch for EXAS stock yet. Tell us why you think EXAS will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
